Peel Hunt reissued their buy rating on shares of Genedrive (LON:GDR) in a research note published on Tuesday.

GDR opened at GBX 27.50 ($0.35) on Tuesday. Genedrive has a 52 week low of GBX 25 ($0.32) and a 52 week high of GBX 44.50 ($0.57).

Genedrive Company Profile

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.

Read More: Relative Strength Index

Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with's FREE daily email newsletter.